Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about EDIT

Recent news which mentions EDIT

< Previous 1 2 3 4 5 6 7 8 Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
Tickers AAPL AGTC AKUS BKKT
Tags OIIM SNPS NWBI
From Benzinga
Editas Medicine's Return On Capital Employed Insights
Tickers EDIT
Tags Earnings Benzinga BZI/ROCE
From Benzinga
Why Editas Medicine Was Winning on Wednesday
Tickers EDIT
Tags Market News Recent Press Releases EDIT
From Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Tickers ALNY AMRN ARQT BMRN
Tags CHRS Financing KTRA
From Benzinga
Editas Medicine: Q2 Earnings Insights
Tickers EDIT
Tags Benzinga Earnings Market News
From Benzinga
Down 35% This Year, Is This Small-Cap Stock a Buy?
Tickers BLUE CRSP EDIT NTLA
Tags EDIT NTLA BLUE
From Motley Fool
The 3 Leaders of the Gene Editing Revolution
Tickers BEAM BIIB CRSP EDIT
Tags EDIT BIIB NTLA
From InvestorPlace
7 Moonshot Investments Upending a $10 Trillion Industry
Tickers AMZN BEAM BIIB CRSP
Tags CSCO BIIB EDIT
From InvestorPlace
Why Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week
Tickers BLUE CRSP EDIT VRTX
Tags VRTX CRSP Market News
From Motley Fool
BMO Initiates Coverage On This Gene Editing Spearhead
Tickers EDIT NTLA
Tags Initiation Analyst Color News
From Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Tickers ADVM AIKI DCTH DNA
Tags Coronavirus Benzinga FDA
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Tickers AIKI BAOS BCAN CETX
Tags EAR KTRA BCAN
From InvestorPlace
16 Stocks Moving in Tuesday's Pre-Market Session
Tickers AERC AUVI BCAN CETX
Tags Small Cap DIDI AUVI
From Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
Tickers ARKG ARKK BNR DNA
Tags ARKG ARKK IONS
From InvestorPlace
Editas Medicine's Return On Capital Employed Insights
Tickers EDIT
Tags EDIT Market News BZI/ROCE
From Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
Tickers CRSP EDIT NTLA
Tags CRSP EDIT ^IXIC
From Motley Fool
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Tickers BBIO BFRI BMY BTTX
Tags Market News PRPH STAB
From Benzinga
These 5-Stock Samplers Have Gotten Whacked. And That's OK
Tickers AAPL ABNB AMGN AMZN
Tags NFLX ABNB Market News
From Motley Fool
Expert Ratings for Editas Medicine
Tickers EDIT
Tags EDIT Market News BZI/AAR
From Benzinga
Editas Medicine: Q1 Earnings Insights
Tickers EDIT
Tags News BZI/Recaps EDIT
From Benzinga
Editas Medicine Earnings Conference Call Is Coming Up, Here's What You Need To Know
Tickers EDIT
Tags EDIT BZI/CONF News
From Benzinga
Editas Medicine's EDIT-301 receives FDA Rare Pediatric Disease designation for Beta Thalassemia
Tickers EDIT
Tags EDIT Small Cap News
From Benzinga
3 Ominous Reasons to Avoid This Biotech Pioneer
Tickers CRSP EDIT NTLA
Tags Recent Press Releases Market News NTLA
From Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
Tickers CRSP EDIT NTLA VRTX
Tags EDIT NTLA Recent Press Releases
From Motley Fool
Who Benefits From Amazon's Stock Split?
Tickers AAPL AMZN BMBL CMG
Tags ONT CMG GS
From Motley Fool
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
Tickers EDIT
Tags Legal Small Cap News
From Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
Tickers ABBV AMRN AMRS AVID
Tags Biotech Earnings NTLA
From Benzinga
27 Stocks Moving in Monday's Pre-Market Session
Tickers AREB ATXI AVGR AVIR
Tags MOTS DDD AREB
From Benzinga
Expert Ratings For Editas Medicine
Tickers EDIT
Tags EDIT Benzinga Analyst Ratings
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Tickers ABCL ADGI AGIO ARYD
Tags ABCL EBS Earnings
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.